This is a $573,760 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to PAK Biosolutions, Inc., a woman-owned small business manufacturer of biopharmaceutical equipment and solutions. The contract is for the procurement of one PAK System continuous manufacturing instrument, which is a specialized scientific instrument used in pharmaceutical process development and manufacturing. This contract has been designated as a Total...
This federal contract award is for an Integrated Continuous Purification System, awarded by the Food and Drug Administration (FDA) to PAK Biosolutions, Inc., a woman-owned small business manufacturer of biopharmaceutical equipment and solutions. The $504,772 firm-fixed price purchase order contract has a completion date of February 22, 2028 and was designated as a total small business set-aside. PAK Biosolutions specializes in continuous manufacturing instruments and integrated bioprocessing...
The Department of Health and Human Services Food and Drug Administration awarded a $33,175 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, HiFi Express Template Prep Kit 2.0, Sequel Binding Kit 3.0, Sequel Sequencing Kit 3.0, and SMRT Cell 1M v3 LR Tray. The place of performance is Silver Spring, Maryland. The contract period runs from August 29, 2023 through March 30, 2024. As the prime...
This federal contract award, with ID HHSF223201400658P, was issued by the Food and Drug Administration (FDA), a civilian agency, to Protasis Corporation, a for-profit manufacturer, for the delivery of lab equipment. The fixed-price purchase order, awarded on August 22, 2014, has a ceiling value of $62,375.00 and an ultimate completion date of October 7, 2017. The contract does not have a set-aside designation. Without additional information on the original solicitation, the specific products...
The Department of Health and Human Services' Food and Drug Administration awarded a $120,000 firm fixed price purchase order to Global Life Sciences Solutions USA LLC for a BIACORE 1K+ Upgrade Kit. The prime contractor, a subsidiary of Danaher Corporation, will provide the upgrade kit to support the FDA's work. Performance will take place in Marlborough, Massachusetts over approximately one year. No set aside designation or subcontractors were indicated. The award falls under HHS/FDA programs...
The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
This firm fixed price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Samyak Solutions, Inc. for Glycoworks Rapifluor mass spectrometer N-glycan kits and supplies. The $26,162 contract is being performed in Silver Spring, Maryland through December 2023. The solicitation requested quotations for these Glycoworks products to support the FDA's analytical needs. As a total small business set-aside awarded under the Schedule, the contract...
This federal contract award was made by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The $158,720.18 purchase order is for the addition of items from Requisition #1199385, with a completion date of October 30, 2018. This contract is a firm-fixed price award and was set aside for small businesses. Pacific Biosciences has...
This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $240,000 worth of pharmaceutical products to support domestic manufacturing and regulatory purposes. We Pharma, Inc. will provide the products in Takoma Park, Maryland by September 30, 2023 under a firm fixed price arrangement. As the FDA works to ensure the safety and effectiveness of drugs and medical devices, this contract will help the agency assess pharmaceutical manufacturing...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $20,940.38 delivery order contract to Biomerieux, Inc. for supplies. The prime contractor Biomerieux, Inc. will perform the work at its Calverton, Maryland facility. The firm fixed price contract runs from May 18, 2022 through July 28, 2026. No additional details were provided regarding the specific supplies requested under the original solicitation. The HHS FDA regulates food and drugs to ensure...